Real-world effectiveness of teriparatide on fracture reduction in patients with osteoporosis and comorbidities or risk factors for fractures: Integrated analysis of 4 prospective observational studies.
Saved in:
| Title: | Real-world effectiveness of teriparatide on fracture reduction in patients with osteoporosis and comorbidities or risk factors for fractures: Integrated analysis of 4 prospective observational studies. |
|---|---|
| Authors: | Langdahl BL; Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark. Electronic address: bente.langdahl@aarhus.rm.dk., Silverman S; Cedars-Sinai/UCLA Medical Center and OMC Clinical Research Center, Beverly Hills, CA, USA. Electronic address: stuarts@bhillsra.com., Fujiwara S; Health Management and Promotion Center, Hiroshima Atomic Bomb Casualty Council, Hiroshima, Japan., Saag K; Division of Clinical Immunology and Rheumatology, Center for Education and Research on Therapeutics University of Alabama at Birmingham, Birmingham, AL, USA. Electronic address: ksaag@uabmc.edu., Napoli N; Division of Endocrinology and Diabetes, Campus Bio-Medico University of Rome, Rome, Italy; IRCCS Istituto Ortopedico Galeazzi, Milan, Italy., Soen S; Department of Orthopaedic Surgery and Rheumatology, Kindai University Nara Hospital, Ikoma, Japan. Electronic address: souen@med.kindai.ac.jp., Enomoto H; Eli Lilly Japan K.K., Kobe, Japan. Electronic address: enomoto_hiroyuki@lilly.com., Melby TE; Syneos Health, Raleigh, NC, USA. Electronic address: thomas.melby@syneoshealth.com., Disch DP; Eli Lilly and Company, Indianapolis, IN, USA., Marin F; Lilly Research Centre, Windlesham, UK. Electronic address: marin_fernando@lilly.com., Krege JH; Eli Lilly and Company, Indianapolis, IN, USA. Electronic address: krege_john_henry@lilly.com. |
| Source: | Bone [Bone] 2018 Nov; Vol. 116, pp. 58-66. Date of Electronic Publication: 2018 Jul 18. |
| Publication Type: | Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Science Country of Publication: United States NLM ID: 8504048 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2763 (Electronic) Linking ISSN: 18732763 NLM ISO Abbreviation: Bone Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 30021126 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Real-world effectiveness of teriparatide on fracture reduction in patients with osteoporosis and comorbidities or risk factors for fractures: Integrated analysis of 4 prospective observational studies. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Langdahl+BL%22">Langdahl BL</searchLink>; Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark. Electronic address: bente.langdahl@aarhus.rm.dk.<br /><searchLink fieldCode="AU" term="%22Silverman+S%22">Silverman S</searchLink>; Cedars-Sinai/UCLA Medical Center and OMC Clinical Research Center, Beverly Hills, CA, USA. Electronic address: stuarts@bhillsra.com.<br /><searchLink fieldCode="AU" term="%22Fujiwara+S%22">Fujiwara S</searchLink>; Health Management and Promotion Center, Hiroshima Atomic Bomb Casualty Council, Hiroshima, Japan.<br /><searchLink fieldCode="AU" term="%22Saag+K%22">Saag K</searchLink>; Division of Clinical Immunology and Rheumatology, Center for Education and Research on Therapeutics University of Alabama at Birmingham, Birmingham, AL, USA. Electronic address: ksaag@uabmc.edu.<br /><searchLink fieldCode="AU" term="%22Napoli+N%22">Napoli N</searchLink>; Division of Endocrinology and Diabetes, Campus Bio-Medico University of Rome, Rome, Italy; IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Soen+S%22">Soen S</searchLink>; Department of Orthopaedic Surgery and Rheumatology, Kindai University Nara Hospital, Ikoma, Japan. Electronic address: souen@med.kindai.ac.jp.<br /><searchLink fieldCode="AU" term="%22Enomoto+H%22">Enomoto H</searchLink>; Eli Lilly Japan K.K., Kobe, Japan. Electronic address: enomoto&#95;hiroyuki@lilly.com.<br /><searchLink fieldCode="AU" term="%22Melby+TE%22">Melby TE</searchLink>; Syneos Health, Raleigh, NC, USA. Electronic address: thomas.melby@syneoshealth.com.<br /><searchLink fieldCode="AU" term="%22Disch+DP%22">Disch DP</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Marin+F%22">Marin F</searchLink>; Lilly Research Centre, Windlesham, UK. Electronic address: marin&#95;fernando@lilly.com.<br /><searchLink fieldCode="AU" term="%22Krege+JH%22">Krege JH</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA. Electronic address: krege&#95;john&#95;henry@lilly.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228504048%22">Bone</searchLink> [Bone] 2018 Nov; Vol. 116, pp. 58-66. <i>Date of Electronic Publication: </i>2018 Jul 18. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science%22">Elsevier Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8504048 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-2763 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2218732763%22">18732763 </searchLink><i>NLM ISO Abbreviation: </i>Bone <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30021126 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.bone.2018.07.013 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 58 Titles: – TitleFull: Real-world effectiveness of teriparatide on fracture reduction in patients with osteoporosis and comorbidities or risk factors for fractures: Integrated analysis of 4 prospective observational studies. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Langdahl BL – PersonEntity: Name: NameFull: Silverman S – PersonEntity: Name: NameFull: Fujiwara S – PersonEntity: Name: NameFull: Saag K – PersonEntity: Name: NameFull: Napoli N – PersonEntity: Name: NameFull: Soen S – PersonEntity: Name: NameFull: Enomoto H – PersonEntity: Name: NameFull: Melby TE – PersonEntity: Name: NameFull: Disch DP – PersonEntity: Name: NameFull: Marin F – PersonEntity: Name: NameFull: Krege JH IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: 2018 Nov Type: published Y: 2018 Identifiers: – Type: issn-electronic Value: 1873-2763 Numbering: – Type: volume Value: 116 Titles: – TitleFull: Bone Type: main |
| ResultId | 1 |